Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWhen you stop weight loss injections such as tirzepatide (Mounjaro) or semaglutide (Wegovy), appetite typically returns to its pre-treatment level within weeks, and most people regain a significant proportion of the weight they lost. Clinical trial data reviewed by NICE confirm this pattern: the medicines manage appetite and metabolism while you take them, not permanently. That does not mean stopping is always wrong, but it is a decision that deserves careful clinical thought. These are prescription-only weight loss injections and any change to treatment should be made with your prescriber, not unilaterally.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The clearest evidence comes from the STEP 1 extension study, which followed participants after they stopped semaglutide 2.4mg at 68 weeks. Within a year of stopping, participants had regained roughly two-thirds of the weight they had lost. Hunger levels, measured by validated questionnaires, returned almost to baseline within weeks. Similar findings emerged from the tirzepatide programme: the benefits observed in SURMOUNT-1 (the landmark trial behind the Mounjaro weight loss injection) were sustained only while treatment continued, as NICE's appraisal of tirzepatide (TA1026) makes clear when setting out its long-term treatment framework.
Why does this happen? GLP-1 and dual GIP/GLP-1 medicines work by moderating the hormonal signals that drive appetite and gastric emptying. When you stop taking them, those signals rebound. That is biology, not failure. The misconception that a course of injections permanently resets your appetite is understandable (the suppression during treatment can feel fundamental) but the evidence does not support it. Appetite comes back. What you do with that, and how prepared you are, matters enormously.
The practical implication is that stopping weight loss injections without a plan tends to lead to rapid hunger-driven eating, which is why structured stopping or continuation is generally preferred to an unplanned break.
Most people notice their appetite returning within one to two weeks of stopping, sometimes sooner at lower doses, sometimes a little later after a period at higher doses, reflecting the longer half-life of some formulations. Food noise, that persistent background preoccupation with eating that many patients describe, tends to come back in the same window.
Weight starts to creep up, initially from restored appetite and then, over months, from the compound effect of eating closer to previous calorie levels. The NHS medicines information page for tirzepatide reinforces that these medicines are intended to be used alongside a reduced-calorie diet and increased physical activity, and that the lifestyle work you do during treatment is the part that persists after you stop.
Gastrointestinal symptoms that were present during treatment (nausea, constipation, reflux) generally ease within days of stopping. Some people find this the most immediately noticeable change, and it can feel like relief. Blood sugar control, for those on the borderline of prediabetes or managing type 2 diabetes, should be monitored after stopping because the beneficial effect on glucose metabolism also wanes.
If you are thinking about what to eat during or after treatment to support your results, our page on what to eat when on weight loss injections covers the nutritional approach most relevant to this period.
Yes, considerably. There are several different reasons people stop weight loss injections: they have reached a weight they are comfortable maintaining; they are pausing due to cost or supply; they are stopping on medical advice; or they are stopping because of side effects. The appropriate response differs in each case, and this is worth raising with your prescriber rather than deciding alone.
Stopping because of intolerable side effects is different from stopping because treatment worked and you feel confident managing without it. In the latter situation, building in strong lifestyle habits before stopping (regular protein intake, sustainable movement, sleep) gives you the best foundation. Some people also find that stopping gradually, where clinically appropriate, smooths the transition, though the evidence base for tapering specifically as a regain-prevention strategy is still developing.
If cost is the factor, our page looking honestly at what cheap weight loss injections really means in the UK may help you think through the options. There is also a broader question about whether stopping is the right framing at all: whether stopping weight loss injections entirely is the right decision for you is exactly the kind of conversation our prescribers have regularly.
A structured plan makes a measurable difference to outcomes. Clinical guidance, including NICE's framework for both tirzepatide and semaglutide, treats weight management as a long-term endeavour rather than a fixed course. The medicines are tools, not cures, and stopping them shifts the management responsibility back to lifestyle and, sometimes, other interventions.
Before stopping, it is worth discussing with your prescriber: your current weight and whether you are at a stable plateau; your lifestyle habits and how sustainable they are off medication; and whether a pause rather than a permanent stop makes more sense given your goals. Some people return to treatment after a break with good outcomes. Others manage well long-term after stopping, particularly those who used the treatment period to build robust habits around eating and activity, and our page on what to eat when taking weight loss injections goes into this in more depth.
You can read more about the broader landscape of weight loss treatments available in the UK, or explore how treatment journeys like this are managed at our clinical service. If you have questions about what stopping might mean for your specific situation, a free consultation with a named prescriber is the right starting point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.